CTOs on the Move

Accreditation Council for Graduate Medical Educa

www.acgme.org

 
The Accreditation Council for Graduate Medical Education (ACGME) is a private, non-profit, professional organization responsible for the accreditation of approximately 10,000 residency and fellowship programs and the approximately 800 institutions that sponsor these programs in the United States. Residency and fellowship programs educate approximately 125,000 resident and fellow physicians in 150 specialties and subspecialties. The ACGME`s mission is to improve health care and population health by assessing and advancing the quality of resident physicians` education through accreditation. We imagine a world characterized by: • A structured approach to evaluating the competency of all residents and fellows, • Motivated physician role ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.acgme.org
  • 401 North Michigan Avenue Suite 2000
    Chicago, IL USA 60611
  • Phone: 312.755.5000

Executives

Name Title Contact Details

Similar Companies

New Century Health

New Century Health delivers specialty care management solutions that leverage technology and evidence-based medicine at the point-of-care, with a focus on oncology and cardiology. Our services promote the most effective treatment, reduce variability, improve clinical outcomes, and optimize cost-effectiveness.

Blue Cross and Blue Shield of Mississippi (BCBSMS)

Blue Cross and Blue Shield of Mississippi (BCBSMS) is a Jackson, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JJ WIld

JJ WIld is a Canton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MediConnect Global

MediConnect Global is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

www.mavericktx.com

Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.